Guard Medical reports an $11 million Series B investment for its novel NPseal™, the first all-in-one NPWT surgical dressing 

Miami,  April 6, 2022 –  Privately-held company Guard Medical Inc. today announces the completion of a Series B investment of $11 million to support commercialization and clinical studies of its next generation Negative Pressure Wound Therapy (NPWT) dressing NPseal™ for the treatment of closed surgical incisions. NPseal™ is an easy-to-use and cost-effective NPWT surgical dressing with an integrated pump that […]